Symbol="ENTX"
AssetType="Common Stock"
Name="Entera Bio Ltd"
Description="Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally administered large molecule therapies for unmet medical needs. The company is headquartered in Jerusalem, Israel."
CIK="1638097"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, IL"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="17052100"
EBITDA="-10871000"
PERatio="None"
PEGRatio="None"
BookValue="0.286"
DividendPerShare="0"
DividendYield="0"
EPS="-0.39"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-496.91"
ReturnOnAssetsTTM="-0.463"
ReturnOnEquityTTM="-0.833"
RevenueTTM="22000"
GrossProfitTTM="33000"
DilutedEPSTTM="-0.39"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.915"
AnalystTargetPrice="6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="63.37"
PriceToBookRatio="1.262"
EVToRevenue="13.56"
EVToEBITDA="-0.277"
Beta="1.834"
num_52WeekHigh="1.65"
num_52WeekLow="0.472"
num_50DayMovingAverage="0.797"
num_200DayMovingAverage="0.842"
SharesOutstanding="28814000"
DividendDate="None"
ExDividendDate="None"
symbol="ENTX"
open="0.66"
high="0.66"
low="0.56"
price="0.60"
volume="95559.00"
latest_trading_day="2023-08-18"
previous_close="0.60"
change="-0.00"
change_percent="-0.1674%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="69"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="31"
Volume_recent_avg="46325"
Change_recent_avg="-0.01"
Delta_recent_avg="0.07"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="31"
Aroon_momentum_negative="69"
image_negative_thumbnail_id_1="141"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0035.jpeg"
image_negative_thumbnail_id_2="102"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0074.jpeg"
image_neutral_thumbnail_id_1="566"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0033.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="957"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0119.jpeg"
image_positive_thumbnail_id_2="669"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0039.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1188"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
